Big Pharma Concocts First Swine Flu Vaccine

It looks like governments around the world will either force these vaccinations on the public or launch a massive propaganda campaign to trick you into submitting to a jab. If they attempt to force these untested and essentially experimental vaccinations on you, cite the Nuremberg Code, which states: “The voluntary consent of the human subject is essential.” No experimental vaccine should be “conducted where there is an a priori reason to believe that death or disabling injury will occur, except, perhaps, in those experiments where the experimental physicians also serve as a subjects.” In addition to the “experimental physicians” submitting to their own toxins, Obama, every member of Congress, the CEOs of the drug companies, all members of WHO and the United Nations, all members of the CFR and Bilderberg, etc., should submit to a jab. A third party should be on hand to make sure these folks do not get a saline injection instead of the vaccine:

Swiss drugs giant Novartis has completed a first batch of swine flu vaccine for pre-clinical trials and aims to make a version available from September, the company said.

“Novartis has successfully completed the production of the first batch of influenza A(H1N1) vaccine, weeks ahead of expectations,” the company said. The 10-litre batch “will be used for pre-clinical evaluation and testing and is also being considered for use in clinical trials”.

Novartis hopes to start clinical trials in July and “expects licensure in the fall (September to November) of 2009″, it said. It added that “more than 30 governments have made requests to Novartis to supply them with influenza A(H1N1) vaccine ingredients.”

The company used cell-based technology to produce the vaccine, a faster method than the traditional technology that uses eggs, according to Novartis. (AFP, June12, 2009)

Read full AFP report


Articles by: Global Research

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Center of Research on Globalization grants permission to cross-post original Global Research articles on community internet sites as long as the text & title are not modified. The source and the author's copyright must be displayed. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]